Yu W - Search Results

1

IL-35: New Target for Immunotherapy Targeting the Tumor Microenvironment.

Yi P, Yu W, Xiong Y, Dong Y, Huang Q, Lin Y, Du Y, Hua F. Yi P, et al. Among authors: yu w. Mol Cancer Ther. 2024 Feb 1;23(2):148-158. doi: 10.1158/1535-7163.MCT-23-0242. Mol Cancer Ther. 2024. PMID: 37988561 Review.

2

Effect of Chitosan Magnetic Nanoparticles Loaded with Ang2-siRNA Plasmids on the Growth of Melanoma Xenografts in Nude Mice.

Shan X, Yu W, Ni X, Xu T, Lei C, Liu Z, Hu X, Zhang Y, Cai B, Wang B. Shan X, et al. Among authors: yu w. Cancer Manag Res. 2020 Aug 20;12:7475-7485. doi: 10.2147/CMAR.S250479. eCollection 2020. Cancer Manag Res. 2020. PMID: 32904466 Free PMC article.

3

CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study.

Qian JJ, Hu X, Wang Y, Zhang Y, Du J, Yang M, Tong H, Qian WB, Wei J, Yu W, Lou YJ, Mao L, Tao Meng H, You LS, Wang L, Li X, Huang X, Cao LH, Zhao JZ, Yan Yan X, Chen YB, Chen Y, Zhang SJ, Jin J, Hu J, Zhu HH. Qian JJ, et al. Among authors: yu w. Cancer Med. 2020 Aug;9(15):5327-5334. doi: 10.1002/cam4.3079. Epub 2020 Jun 3. Cancer Med. 2020. PMID: 32492289 Free PMC article.

4

IRF4 promotes cell proliferation by JNK pathway in multiple myeloma.

Zhang S, Xu J, Wu S, Wang R, Qu X, Yu W, Li J, Chen L. Zhang S, et al. Among authors: yu w. Med Oncol. 2013;30(2):594. doi: 10.1007/s12032-013-0594-8. Epub 2013 May 12. Med Oncol. 2013. PMID: 23666852

5

Prognostic value and efficacy evaluation of novel drugs for cytogenetic aberrations in multiple myeloma: a meta-analysis.

Yu W, Li J, Chen L. Yu W, et al. Int J Clin Exp Med. 2014 Nov 15;7(11):4051-62. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25550914 Free PMC article.

6

Long Non-Coding RNA MEG3 Functions as a Competing Endogenous RNA to Regulate HOXA11 Expression by Sponging miR-181a in Multiple Myeloma.

Shen X, Bai H, Zhu H, Yan Q, Yang Y, Yu W, Shi Q, Wang J, Li J, Chen L. Shen X, et al. Among authors: yu w. Cell Physiol Biochem. 2018;49(1):87-100. doi: 10.1159/000492846. Epub 2018 Aug 22. Cell Physiol Biochem. 2018. PMID: 30134227 Free article.

7

Platelet-rich plasma: a promising product for treatment of peripheral nerve regeneration after nerve injury.

Yu W, Wang J, Yin J. Yu W, et al. Int J Neurosci. 2011 Apr;121(4):176-80. doi: 10.3109/00207454.2010.544432. Epub 2011 Jan 19. Int J Neurosci. 2011. PMID: 21244302

8

Promoter hypermethylation inﬂuences the suppressive role of long non-coding RNA MEG3 in the development of multiple myeloma.

Yu W, Shi Q, Wu C, Shen X, Chen L, Xu J. Yu W, et al. Exp Ther Med. 2020 Jul;20(1):637-645. doi: 10.3892/etm.2020.8723. Epub 2020 May 6. Exp Ther Med. 2020. PMID: 32537021 Free PMC article.

9

Adipose-derived stem cells combined with platelet-rich plasma enhance wound healing in a rat model of full-thickness skin defects.

Ni X, Shan X, Xu L, Yu W, Zhang M, Lei C, Xu N, Lin J, Wang B. Ni X, et al. Among authors: yu w. Stem Cell Res Ther. 2021 Apr 6;12(1):226. doi: 10.1186/s13287-021-02257-1. Stem Cell Res Ther. 2021. PMID: 33823915 Free PMC article.

10

Circulating microRNA 483-5p as a novel biomarker for diagnosis survival prediction in multiple myeloma.

Qu X, Zhao M, Wu S, Yu W, Xu J, Xu J, Li J, Chen L. Qu X, et al. Among authors: yu w. Med Oncol. 2014 Oct;31(10):219. doi: 10.1007/s12032-014-0219-x. Epub 2014 Sep 13. Med Oncol. 2014. PMID: 25216866 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

15,479 results

Search Page